CD4 and systemic sclerosis: Anti-CD11a mAb significantly diminished the levels of IgG production by autologous B cells co-cultured with SSc CD4+ T cells or 5-azaC-treated CD4+ T cells but its isotype control, IgG, did not (P <0.05 and P <0.05, respectively; Figure 4C,D).